Gould Asset Management LLC Gilead Sciences, Inc. Transaction History

Gould Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $277,351 - $322,056	-3,834 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$62.63 - $80.22 $240,123 - $307,563	3,834 New	3,834 $287,000
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $242,352 - $268,328	-3,400 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $26,665 - $31,104	-411 Reduced 10.78%	3,400 $241,000
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $277,593 - $338,416	3,811 New	3,811 $287,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Gould Asset Management LLC , based on Form 13F filings with the SEC.

Stay updated on Gould Asset Management LLC with notifications on news.